Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate.

× No keyword cloud information.

22 in total

1. Interaction of ibuprofen and warfarin on primary haemostasis.

Authors: S Schulman; K Henriksson
Journal: Br J Rheumatol Date: 1989-02

2. Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement.

Authors: H A van Heereveld; R F Laan; F H van den Hoogen; M C Malefijt; I R Novakova; L B van de Putte
Journal: Ann Rheum Dis Date: 2001-10 Impact factor: 19.103

3. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.

Authors: C W Colwell; D K Collis; R Paulson; J W McCutchen; G T Bigler; S Lutz; M E Hardwick
Journal: J Bone Joint Surg Am Date: 1999-07 Impact factor: 5.284

4. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.

Authors: A G Turpie; A S Gallus; J A Hoek
Journal: N Engl J Med Date: 2001-03-01 Impact factor: 91.245

5. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty.

Authors: R H White; S Gettner; J M Newman; K B Trauner; P S Romano
Journal: N Engl J Med Date: 2000-12-14 Impact factor: 91.245

6. Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study.

Authors: J S Ginsberg; F Turkstra; H R Buller; B MacKinnon; D Magier; J Hirsh
Journal: Arch Intern Med Date: 2000-03-13

7. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors: C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal: N Engl J Med Date: 2000-11-23 Impact factor: 91.245

Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate.

1. Interaction of ibuprofen and warfarin on primary haemostasis.

2. Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement.

3. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.

4. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.

5. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty.

6. Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study.

7. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Review 8. Cyclooxygenase inhibition and thrombogenicity.

9. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

10. Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.

Review 1. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.